Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Fetal warfarin syndrome"'
Publikováno v:
Journal of Womens Health Care and Management. 2
Autor:
A Castelo, A Viveiros Monteiro, Iara Aimê Cardoso, Lino Patrício, M Plancha Santos, T Mano, A Grazina, R Cruz Ferreira, M J N N Alves, Ferreira, Andresa Vieira Machado, Augusta Borges, P Garcia Bras
Publikováno v:
European Heart Journal. 41
Background Mechanical heart valves (MHV) and their absolute need for adequate anticoagulation poses a challenge for pregnancy, either due to warfarin fetotoxicity or an increased risk of maternal thromboembolism. This represents a unique patient (P)
Autor:
Thomas Chetot, Isabelle Fourel, Shira Taufana, Sébastien Lefebvre, Etienne Benoit, Virginie Lattard, Marjorie Mouette-Bonnet
Publikováno v:
Toxicology Letters
Toxicology Letters, Elsevier, 2020, 333, pp.71-79. ⟨10.1016/j.toxlet.2020.07.034⟩
Toxicology Letters, Elsevier, 2020, 333, pp.71-79. ⟨10.1016/j.toxlet.2020.07.034⟩
International audience; All vitamin K antagonist active substances used as rodenticides were reclassified in 2016 by the European authorities as active substances "toxic for reproduction", using a "read-across" alternative method based on warfarin, a
Publikováno v:
Reproductive Toxicology
Reproductive Toxicology, Elsevier, 2020, 93, pp.131-136. ⟨10.1016/j.reprotox.2020.02.003⟩
Reproductive Toxicology, Elsevier, 2020, 93, pp.131-136. ⟨10.1016/j.reprotox.2020.02.003⟩
International audience; Vitamin K antagonists (VKA) are not recommended during pregnancy because warfarin (a first-generation VKA) is associated with a malformation syndrome "the fetal warfarin syndrome" (FWS). VKA are also used for rodent management
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eed2964532c35961eeb458a3a3089b75
https://hal-vetagro-sup.archives-ouvertes.fr/hal-02501177
https://hal-vetagro-sup.archives-ouvertes.fr/hal-02501177
Publikováno v:
International Journal of Orthopaedics Sciences. 7:1022-1023
A 35-week gestation preterm female baby whose mother was treated with anti-coagulants for maternal heart disease (severe mitral stenosis) - intake of warfarin 6mg once daily throughout pregnancy, was born with dysmorphic features and asphyxia requiri
Publikováno v:
Birth Defects Research Part A: Clinical and Molecular Teratology. 106:142-147
Background Fetal exposure to maternal ingestion of warfarin is known to produce certain dysmorphic features in the neonate, known as fetal warfarin syndrome (FWS). There is a general consensus that maternal intake of warfarin at a daily dose of 5 mg
Autor:
Juliane Dantas Seabra Garcez, Tarso Augusto Duenhas Accorsi, João Ricardo Cordeiro Fernandes, Vitor Emer Egypto Rosa, Antonio Sergio de Santis Andrade Lopes, Flávio Tarasoutchi, Walkiria Samuel Avila, Pablo Maria Alberto Pomerantzeff
Publikováno v:
Arquivos Brasileiros de Cardiologia
Arquivos Brasileiros de Cardiologia, Vol 105, Iss 4, Pp 426-429 (2015)
Arquivos Brasileiros de Cardiologia, Vol 105, Iss 4, Pp 426-429 (2015)
Prosthetic thrombosis is a rare complication, but it has high mortality and morbidity. Young women of childbearing age that have prosthetic heart valves are at increased risk of thrombosis during pregnancy due to changes in coagulation factors. Antic
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.